Joinn Laboratories(China)Co.,Ltd.
603127
Hisse Senetlerindeki Sıralama
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Hisse Fiyatı
$6.82
Piyasa Değeri
$4.30B
Değişim (1 gün)
-6.30%
Değişim (1 yıl)
48.79%
Ülke
CN
Ticaret Joinn Laboratories(China)Co.,Ltd. (603127)
Kategori
Healthcare
Joinn Laboratories(China)Co.,Ltd. (603127) için gelir
Oct 2026 itibarıyla gelir TTM: 0
Joinn Laboratories(China)Co.,Ltd. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Joinn Laboratories(China)Co.,Ltd. için 2012 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2025 | $236.93M | -14.32% |
| 2024 | $276.52M | -17.64% |
| 2023 | $335.73M | 2.11% |
| 2022 | $328.79M | 37.79% |
| 2021 | $238.63M | 44.89% |
| 2020 | $164.70M | 79.37% |
| 2019 | $91.82M | 54.50% |
| 2018 | $59.43M | 28.34% |
| 2017 | $46.31M | 32.96% |
| 2016 | $34.83M | 9.47% |
| 2015 | $31.82M | 6.63% |
| 2014 | $29.84M | 25.84% |
| 2013 | $23.71M | 51.82% |
| 2012 | $15.62M | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| $47.35B | - |
US
|
|
| $25.61B | - |
US
|
|
| $2.71B | - |
US
|
|
| - | - |
CN
|
|
| $7.37B | - |
US
|
